Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00702936Phase 4Unknown
Phase 4, randomised trial of telmisartan in acute coronary syndrome (ACS) (2 arms), sponsored by Università Cattolica del Sacro Cuore. Primary endpoint: High sensitivity C-Reactive Protein. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00702936.